✦ LIBER ✦

Immunophenotyping of B-cell chronic lymphocytic leukemia on whole blood sample

✍ Scribed by Nelly, Robillard; Yves, Garreau; Richard, Garand; Régis, Bataille

Book ID: 122104066
Publisher: Portland Press
Year: 1992
Tongue: English
Weight: 134 KB
Volume: 76
Category: Article
ISSN: 0248-4900
DOI: 10.1016/0248-4900(92)90409-T

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinicopathological and immunophenotypic

Clinicopathological and immunophenotypic studies on 12 cases with B cell chronic lymphocytic leukemia

✍ Naoya Nakamura; Sayuri Suzuki; Hideo Segami; Yoshihiro Nozawa; Kunihiko Tominaga 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 601 KB

Advances in the Treatment of B-Cell Chro

Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia || Genetics in chronic lymphocytic leukemia

✍ Keating, Michael J; Tam, Constantine 📂 Article 📅 2012 🏛 Future Medicine Ltd ⚖ 909 KB

Genetic Features of B-Cell Chronic Lymph

Genetic Features of B-Cell Chronic Lymphocytic Leukemia

✍ Stephan Stilgenbauer; Peter Lichter; Hartmut Döhner 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

The Origin of B-Cell Chronic Lymphocytic

The Origin of B-Cell Chronic Lymphocytic Leukemia

✍ Paolo Ghia; Federico Caligaris-Cappio 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Lipoprotein Lipase mRNA Expression in Wh

Lipoprotein Lipase mRNA Expression in Whole Blood Is a Prognostic Marker in B Cell Chronic Lymphocytic Leukemia

✍ Van Bockstaele, F.; Pede, V.; Janssens, A.; Callewaert, F.; Offner, F.; Verhasse 📂 Article 📅 2007 🏛 American Association for Clinical Chemistry 🌐 English ⚖ 298 KB

Decision-tree approach to the immunophen

Decision-tree approach to the immunophenotype-based prognosis of the B-cell chronic lymphocytic leukemia

✍ Mašić, Nikola; Gagro, Alenka; Rabatić, Sabina; Sabioncello, Ante; Dašić, Gorana; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Use of a nonlinear prediction method, such as machine learning, is a valuable choice in predicting progression rate of disease when applied to the highly variable and correlated biological data such as those in patients with chronic lymphocytic leukemia (CLL). In this work, decision-tree approach to